Cargando…
Use of artesunate in the treatment of severe imported malaria in France: review of the effectiveness and real-life safety in two French university hospitals
BACKGROUND: Intravenous artesunate (AS) is the first-line treatment for patients with severe imported malaria (SIM) worldwide. However, after 10 years of use in France, AS hasn’t yet received marketing authorization.The purpose of this study was to assess the real-life effectiveness and safety of AS...
Autores principales: | Bonsergent, M., Tching-Sin, M., Honoré, S., Bertault-Peres, P., Lepelletier, A., Flet, L., Perez, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214604/ https://www.ncbi.nlm.nih.gov/pubmed/37231336 http://dx.doi.org/10.1186/s12879-023-08260-6 |
Ejemplares similares
-
Aspects cliniques et traitements du syndrome inflammatoire multisystémique pédiatrique en réanimation pédiatrique
por: Hanafia, O., et al.
Publicado: (2022) -
What do adult outpatients included in clinical trials know about the investigational drugs being assessed: A cross-sectional study in France
por: Fronteau, Clémentine, et al.
Publicado: (2019) -
Artesunate Dosing in Severe Falciparum Malaria
por: Dondorp, Arjen M., et al.
Publicado: (2012) -
Treatment of imported severe malaria with artesunate instead of quinine - more evidence needed?
por: Cramer, Jakob P, et al.
Publicado: (2011) -
Severe Malaria and Artesunate Treatment, Norway
por: Mørch, Kristine, et al.
Publicado: (2008)